featured
The Omnipod Hybrid Closed-Loop System Improves Management in Adults, Adolescents, and Children With T1D
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Technology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children With Type 1 Diabetes Over 5 Days Under Free-Living Conditions
Diabetes Technol. Ther. 2020 Mar 01;22(3)174-184, JL Sherr, BA Buckingham, GP Forlenza, A Galderisi, L Ekhlaspour, RP Wadwa, L Carria, L Hsu, C Berget, TA Peyser, JB Lee, J O'Connor, B Dumais, LM Huyett, JE Layne, TT LyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.